Virtue Technologies gets buy in from PE firm
By HME News Staff
Updated Tue November 5, 2019
MURFREESBORO, Tenn. - Virtue Technologies, a provider of post-acute healthcare technology solutions, has received an investment from Claritas Capital, a Nashville, Tenn.-based private equity firm. Virtue Technologies, created out of a joint venture between TwelveStone Health Partners and VirtueRN, says it addresses the fragmented market for communicating orders for medical equipment and medications to service providers and patients. “The delivery of post-acute care can often be quite challenging,” said Gibran Ameer, CEO of Virtue Technologies. “Technology is a means to un-complicate and simplify business processes—our solutions do just that. This results in a positive impact to operational efficiencies, costs, revenue cycle and, ultimately, a better patient experience.” TwelveStone Health Partners and VirtueRN joined forces to form Virtue Technologies in early 2018. Previously, TwelveStone received a $4.3 million investment from Claritas Capital last year to fuel expansion efforts for its packaged pharmacy, infusion center and technology platform business lines. It also received a $3.35 million investment from the PE firm in 2017.
Comments